Skip to content

Whole Body Vibration Therapy in Participants With MS Related Balance Deficits

Whole Body Vibration Therapy in Participants With MS Related Balance Deficits

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00510523
Enrollment
80
Registered
2007-08-02
Start date
2006-10-31
Completion date
2007-11-30
Last updated
2013-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

MS, Balance, Multiple Sclerosis

Brief summary

The purpose of this investigation is to determine the effect of Whole Body Vibration Therapy (WBV) on balance in participants with multiple sclerosis (MS) related balance deficits as measured by the NeuroCom Balance Master, the Sapphire IIME EMG Device and the Kurtzke Expanded Disability Status Scale (EDSS) and the Berg Balance Score.

Interventions

Sponsors

Logan College of Chiropractic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Logan student, staff, or faculty or general public with a minimal of 2 year history of diagnosed Multiple Sclerosis (MS)

Exclusion criteria

* Visual or vestibular condition that would affect balance * Non-Ms related systemic illness that would have an adverse effect on balance * Local infection, acute inflammation, injury, tumors or other malignancy, recent wounds, diabetes * Any unstable joints of the lower extremity, recent hip and knee joints or fitted hip or knee pins, bolts and/or plates * Acute thrombosis * Severe migraine, epilepsy * Serious cardiovascular disease, wearing a pacemaker * Any Spinal manipulation within 48 hours * Acute disc herniation, discopathy or spondylolysis * Prescription or herbal muscle stimulants, relaxants, etc. that could affect balance * Any implanted device or prosthesis or intrauterine IUD type of device * Pregnancy

Design outcomes

Primary

MeasureTime frame
NeuroCom Balance Master
SF-EMG Nerve conduction velocity test
Berg balance score

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026